What are the side effects of third generation osimertinib?
Although the third-generation targeted drug osimertinib (osimertinib) has a significant therapeutic effect on non-small cell lung cancer, some side effects may also occur during use.
Skin and nail reactions: More than half of patients may experience skin problems such as rash, dry skin, and itching. Additionally, nail infection or inflammation is a relatively common side effect.
Gastrointestinal discomfort: About one-third of patients report diarrhea, and accompanying symptoms may include nausea or loss of appetite. These gastrointestinal symptoms can usually be relieved by adjusting the patient's diet or giving appropriate medication.
Hematological abnormalities: Approximately 10% to 20% of patients may develop hematological abnormalities such as anemia or leukopenia after taking osimertinib. Therefore, it is particularly important to monitor blood routine regularly in order to detect and deal with these potential problems in time.

Respiratory problems: Although rare, osimertinib may cause interstitial lung disease (ILD), with an incidence ranging from 1% to 3%. Patients should pay close attention to whether symptoms of ILD such as dyspnea and cough occur.
Electrocardiogram changes:QT Interval prolongation is another potential side effect of osimertinib. Although this side effect is uncommon, it is recommended that patients undergo regular electrocardiogram examinations to ensure the safety of the medication.
Eye discomfort: A small number of patients may experience symptoms such as blurred vision or dry eyes. These eye reactions are generally mild, but still require the patient's attention.
Serious side effects: In addition to the common side effects mentioned above, osimertinib may also cause some serious adverse reactions, such as interstitial pneumonia syndrome, vasogenic edema, liver function damage, and cardiac problems, such as heart failure and abnormal cardiac function. Although the incidence of these serious side effects is low, if they occur, you need to stop taking the drug immediately and seek medical attention.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)